Literature DB >> 9861973

Possible antibiotic-associated colitis in a dog.

M D Willard1, B Berridge, A Braniecki, D Bouley.   

Abstract

A Poodle referred for renal disease developed severe colonic disease characterized by total mucosal collapse and necrosis. The onset of colonic disease was temporally related to administration of antibiotics. On 3 occasions, bacterial culture of fecal samples yielded only Streptococcus pyogenes, Pseudomonas aeruginosa, and Candida albicans, suggesting that the colonic bacterial flora was severely disrupted. Findings, although not conclusive, were suggestive of antibiotic-associated colitis that ultimately proved fatal. Colonoscopy should be considered for dogs with unduly severe large-bowel diarrhea associated with antibiotic treatment and can be done with minimal restraint and bowel preparation, if necessary. Nonselective bacterial culture of fecal samples should be considered for dogs with unduly severe large-bowel diarrhea associated with antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861973

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  A GC-Rich Prophage-Like Genomic Region of Mycoplasma bovirhinis HAZ141_2 Carries a Gene Cluster Encoding Resistance to Kanamycin and Neomycin.

Authors:  Inna Lysnyansky; Ilya Borovok
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

2.  Characterization of Streptococcus pyogenes from Animal Clinical Specimens, Spain.

Authors:  Ana Isabel Vela; Pilar Villalón; Juan Antonio Sáez-Nieto; Gema Chacón; Lucas Domínguez; José Francisco Fernández-Garayzábal
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

3.  Effect of oral administration of metronidazole or prednisolone on fecal microbiota in dogs.

Authors:  Hirotaka Igarashi; Shingo Maeda; Koichi Ohno; Ayako Horigome; Toshitaka Odamaki; Hajime Tsujimoto
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.